Comparison results
| Results: Differences General | ✘Tumors of the lacrimal glands | ✘Systemic aspergillosis | ||||
| Related research | Analogs | Analogs | ||||
| ||||||
| Distinctive symptoms | ||||||
| Register, to see more distinctive signs of diseases and studies | 100% | — | ||||
| Register, to see more distinctive signs of diseases and studies | — | 100% | ||||
| cries a lot | 98% | — | ||||
| systemic aspergillosis | — | 98% | ||||
| tumors of the lacrimal glands | 85% | — | ||||
| lung aspergilloma | — | 61% | ||||
| has a swelling of the eye | 80% | — | ||||
| chronic leukemia | — | 47% | ||||
| malignant arterial hypertension | 80% | — | ||||
| acute leukemia | — | 44% | ||||
| benign epithelial tumors | 73% | — | ||||
| immunodeficiency | — | 44% | ||||
| exophthalmos | 71% | — | ||||
| chronic granulomatous disease | — | 38% | ||||
| glaucoma | 65% | — | ||||
| leukemia | — | 38% | ||||
| does not like touching | 63% | — | ||||
| skin cancer | — | 37% | ||||
| does not tolerate pain | 55% | — | ||||
| metastases | — | 33% | ||||
| benign neoplasms | 54% | — | ||||
| abscess | — | 32% | ||||
| vascular tumor | 53% | — | ||||
| bacteremia | — | 32% | ||||
| hypertension | 50% | — | ||||
| a history of organ transplantation | — | 32% | ||||
| increased | 43% | — | ||||
| sepsis | — | 32% | ||||
| cancer | 49% | 29% | ||||
| papules | — | 31% | ||||
| history of surgery | 43% | 35% | ||||
| impaired lung function | — | 28% | ||||
| blood diseases | — | 27% | ||||
| skin problems | — | 27% | ||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
